• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于经胸超声心动图的新型冠状病毒肺炎患者不良事件风险预测模型

Transthoracic Echocardiography-Based Prediction Model of Adverse Event Risk in Patients with COVID-19.

作者信息

Golukhova Elena Zelikovna, Slivneva Inessa Viktorovna, Mamalyga Maxim Leonidovich, Marapov Damir Ildarovich, Alekhin Mikhail Nikolaevich, Rybka Mikhail Mikhailovich, Volkovskaya Irina Vasilevna

机构信息

A.N. Bakulev National Medical Scientific Center for Cardiovascular Surgery, Ministry of Health of the Russian Federation, 121552 Moscow, Russia.

Department of Emergency Ultrasound and Functional Diagnostics, A.N. Bakulev National Medical Scientific Center for Cardiovascular Surgery, Ministry of Health of the Russian Federation, 121552 Moscow, Russia.

出版信息

Pathophysiology. 2022 Apr 26;29(2):157-172. doi: 10.3390/pathophysiology29020014.

DOI:10.3390/pathophysiology29020014
PMID:35645324
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9149931/
Abstract

Cardiopulmonary disorders cause a significant increase in the risk of adverse events in patients with COVID-19. Therefore, the development of new diagnostic and treatment methods for comorbid disorders in COVID-19 patients is one of the main public health challenges. The aim of the study was to analyze patient survival and to develop a predictive model of survival in adults with COVID-19 infection based on transthoracic echocardiography (TTE) parameters. We conducted a prospective, single-center, temporary hospital-based study of 110 patients with moderate to severe COVID-19. All patients underwent TTE evaluation. The predictors of mortality we identified in univariate and multivariable models and the predictive performance of the model were assessed using receiver operating characteristic (ROC) analysis and area under the curve (AUC). The predictive model included three factors: right ventricle (RV)/left ventricle (LV) area (odds ratio (OR) = 1.048 per 1/100 increase, p = 0.03), systolic pulmonary artery pressure (sPAP) (OR = 1.209 per 1 mm Hg increase, p < 0.001), and right ventricle free wall longitudinal strain (RV FW LS) (OR = 0.873 per 1% increase, p = 0.036). The AUC-ROC of the obtained model was 0.925 ± 0.031 (95% confidence interval (95% CI): 0.863−0.986). The sensitivity (Se) and specificity (Sp) measures of the models at the cut-off point of 0.129 were 93.8% and 81.9%, respectively. A binary logistic regression method resulted in the development of a prognostic model of mortality in patients with moderate and severe COVID-19 based on TTE data. It may also have additional implications for early risk stratification and clinical decision making in patients with COVID-19.

摘要

心肺疾病会显著增加新冠肺炎患者发生不良事件的风险。因此,开发针对新冠肺炎患者合并症的新诊断和治疗方法是主要的公共卫生挑战之一。本研究的目的是分析患者的生存率,并基于经胸超声心动图(TTE)参数建立新冠肺炎成年患者生存的预测模型。我们对110例中重度新冠肺炎患者进行了一项前瞻性、单中心、基于临时医院的研究。所有患者均接受了TTE评估。我们在单变量和多变量模型中确定了死亡率的预测因素,并使用受试者工作特征(ROC)分析和曲线下面积(AUC)评估了模型的预测性能。预测模型包括三个因素:右心室(RV)/左心室(LV)面积(每增加1/100,比值比(OR)=1.048,p = 0.03)、收缩期肺动脉压(sPAP)(每增加1 mmHg,OR = 1.209,p < 0.001)和右心室游离壁纵向应变(RV FW LS)(每增加1%,OR = 0.873,p = 0.036)。所获模型的AUC-ROC为0.925±0.031(95%置信区间(95%CI):0.863−0.986)。在截断点为0.129时,模型的敏感性(Se)和特异性(Sp)分别为93.8%和81.9%。二元逻辑回归方法基于TTE数据建立了中重度新冠肺炎患者死亡率预后模型。它可能对新冠肺炎患者的早期风险分层和临床决策也有额外的意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3f7/9149931/e87325c9dc49/pathophysiology-29-00014-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3f7/9149931/695a09d80437/pathophysiology-29-00014-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3f7/9149931/12ace564ef89/pathophysiology-29-00014-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3f7/9149931/e87325c9dc49/pathophysiology-29-00014-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3f7/9149931/695a09d80437/pathophysiology-29-00014-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3f7/9149931/12ace564ef89/pathophysiology-29-00014-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3f7/9149931/e87325c9dc49/pathophysiology-29-00014-g003.jpg

相似文献

1
Transthoracic Echocardiography-Based Prediction Model of Adverse Event Risk in Patients with COVID-19.基于经胸超声心动图的新型冠状病毒肺炎患者不良事件风险预测模型
Pathophysiology. 2022 Apr 26;29(2):157-172. doi: 10.3390/pathophysiology29020014.
2
[Right ventricular systolic dysfunction as a predictor of adverse outcome in patients with COVID-19].
Kardiologiia. 2020 Dec 15;60(11):1303. doi: 10.18087/cardio.2020.11.n1303.
3
Echocardiographic predictors of adverse short-term outcomes after heart surgery in patients with mitral regurgitation and pulmonary hypertension.二尖瓣反流和肺动脉高压患者心脏手术后不良短期预后的超声心动图预测指标
Heart Surg Forum. 2012 Jun;15(3):E127-32. doi: 10.1532/HSF98.20121008.
4
Ventricular-arterial decoupling is associated with in-hospital adverse events in normotensive pulmonary embolism.室-动脉解耦与血压正常的肺栓塞住院期间不良事件相关。
Int J Cardiovasc Imaging. 2022 Dec;38(12):2655-2665. doi: 10.1007/s10554-022-02677-x. Epub 2022 Jul 15.
5
[Prognostic value of right ventricular dysfunction and derivation of a prognostic model for patients with acute pulmonary thromboembolism].[右心室功能障碍对急性肺血栓栓塞症患者的预后价值及预后模型的推导]
Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Feb;30(2):184-8.
6
Echocardiographic predictors of mortality and morbidity in COVID-19 disease using focused cardiovascular ultrasound.使用聚焦式心血管超声评估COVID-19疾病死亡率和发病率的超声心动图预测指标
Int J Cardiol Heart Vasc. 2022 Apr;39:100982. doi: 10.1016/j.ijcha.2022.100982. Epub 2022 Feb 25.
7
Noninvasive model including right ventricular speckle tracking for the evaluation of pulmonary hypertension.用于评估肺动脉高压的无创模型,包括右心室斑点追踪技术。
World J Cardiol. 2016 Aug 26;8(8):472-80. doi: 10.4330/wjc.v8.i8.472.
8
Feasibility, Prediction and Association of Right Ventricular Free Wall Longitudinal Strain with 30-Day Mortality in Severe COVID-19 Pneumonia: A Prospective Study.右心室游离壁纵向应变对重症新型冠状病毒肺炎患者30天死亡率的可行性、预测价值及相关性:一项前瞻性研究
J Clin Med. 2022 Jun 23;11(13):3629. doi: 10.3390/jcm11133629.
9
Computed tomography and echocardiography in patients with acute pulmonary embolism: part 2: prognostic value.急性肺栓塞患者的计算机断层扫描和超声心动图:第2部分:预后价值。
J Thorac Imaging. 2014 Jan;29(1):W7-12. doi: 10.1097/RTI.0000000000000048.
10
Understanding the role of left and right ventricular strain assessment in patients hospitalized with COVID-19.了解左、右心室应变评估在新冠肺炎住院患者中的作用。
Am Heart J Plus. 2021 Jun;6:100018. doi: 10.1016/j.ahjo.2021.100018. Epub 2021 Jun 1.

引用本文的文献

1
Prognostic models in COVID-19 infection that predict severity: a systematic review.COVID-19 感染中预测严重程度的预后模型:系统评价。
Eur J Epidemiol. 2023 Apr;38(4):355-372. doi: 10.1007/s10654-023-00973-x. Epub 2023 Feb 25.

本文引用的文献

1
COVID-19: Pulmonary and Extra Pulmonary Manifestations.新型冠状病毒肺炎:肺及肺外表现。
Front Public Health. 2021 Sep 28;9:711616. doi: 10.3389/fpubh.2021.711616. eCollection 2021.
2
Tricuspid annular plane systolic excursion (TAPSE) measured by echocardiography and mortality in COVID-19: A systematic review and meta-analysis.超声心动图测量的三尖瓣环平面收缩期位移(TAPSE)与COVID-19死亡率:一项系统评价和荟萃分析。
Int J Infect Dis. 2021 Apr;105:351-356. doi: 10.1016/j.ijid.2021.02.029. Epub 2021 Feb 11.
3
Echocardiography and Multimodality Cardiac Imaging in COVID-19 Patients.
新型冠状病毒肺炎患者的超声心动图及多模态心脏成像
J Cardiovasc Echogr. 2020 Oct;30(Suppl 2):S18-S24. doi: 10.4103/jcecho.jcecho_58_20. Epub 2020 Oct 27.
4
Left and right ventricular longitudinal strains are associated with poor outcome in COVID-19: a systematic review and meta-analysis.左、右心室纵向应变与COVID-19的不良预后相关:一项系统综述和荟萃分析。
J Intensive Care. 2021 Jan 12;9(1):9. doi: 10.1186/s40560-020-00519-3.
5
Thrombosis and Coagulopathy in COVID-19.新型冠状病毒肺炎中的血栓与出凝血障碍。
Curr Probl Cardiol. 2021 Mar;46(3):100742. doi: 10.1016/j.cpcardiol.2020.100742. Epub 2020 Nov 2.
6
Right ventricular dysfunction in critically ill COVID-19 ARDS.危重症 COVID-19 急性呼吸窘迫综合征患者的右心功能障碍。
Int J Cardiol. 2021 Mar 15;327:251-258. doi: 10.1016/j.ijcard.2020.11.043. Epub 2020 Nov 23.
7
Prognostic Utility of Right Ventricular Remodeling Over Conventional Risk Stratification in Patients With COVID-19.新冠肺炎患者右心室重构对常规危险分层的预后价值。
J Am Coll Cardiol. 2020 Oct 27;76(17):1965-1977. doi: 10.1016/j.jacc.2020.08.066.
8
A novel risk score to predict cardiovascular complications in patients with coronavirus disease 2019 (COVID-19): A retrospective, multicenter, observational study.一种预测 2019 冠状病毒病(COVID-19)患者心血管并发症的新型风险评分:一项回顾性、多中心、观察性研究。
Immun Inflamm Dis. 2020 Dec;8(4):638-649. doi: 10.1002/iid3.353. Epub 2020 Sep 24.
9
COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up.COVID-19 与心脏损伤:临床表现、生物标志物、发病机制、诊断、治疗和随访。
Expert Rev Anti Infect Ther. 2021 Mar;19(3):345-357. doi: 10.1080/14787210.2020.1822737. Epub 2020 Sep 28.
10
COVID-19 medical management including World Health Organization (WHO) suggested management strategies.2019冠状病毒病的医疗管理,包括世界卫生组织(WHO)建议的管理策略。
Dis Mon. 2020 Sep;66(9):101068. doi: 10.1016/j.disamonth.2020.101068. Epub 2020 Aug 28.